Natera
Webinar series
Precision decision peer exchange:
MRD-guided surveillance in CRC
Join a small-group, case-based discussion with oncology experts. Each session features a different speaker sharing real-world cases and clinical perspective on integrating Signatera™ ctDNA testing into CRC surveillance and treatment decisions. 

Throughout this series, we will discuss:

  • Guiding shared decision-making before MRD results
  • Interpreting serial negative results to inform next steps
  • Staying ahead of recurrence with serial testing to enable curative-intent therapy
  • Identifying patients eligible for next-line novel therapies with Signatera results
Available sessions:
October:
Monday, October 19 | 8:00 PM ET / 7:00 PM CT / 5:00 PM PT
Dr. Mark Lewis, MD, Director of Gastrointestinal Oncology, Intermountain Healthcare
Wednesday, October 21 | 6:30 PM ET / 5:30 PM CT / 3:30 PM PT
Dr. Despina Siolas, MD, PhD, Medical Oncologist, Weill Cornell Medicine
Thursday, October 22 | 6:30 PM ET / 5:30 PM CT / 3:30 PM PT
Dr. Despina Siolas, MD, PhD, Medical Oncologist, Weill Cornell Medicine
Thursday, October 29 | 8:30 PM ET / 7:30 PM CT / 5:30 PM PT
Dr. Maen Abdelrahim, MD, PhD, B Pharm, Section Chief of Gastrointestinal Medical Oncology, Houston Methodist Neal Cancer Center
November:
Wednesday, November 4 | 6:30 PM ET / 5:30 PM CT / 3:30 PM PT
Dr. Benjamin Adam Weinberg, MD, Associate Professor of Medicine, Lombardi Comprehensive Cancer Center at Georgetown University

Register Now:

Available sessions:

Select all options that apply
Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Meet our speakers:

Despina Siolas
Despina Siolas, MD, PhD
Medical Oncologist
Weill Cornell Medicine
Mark Lewis
Mark Lewis, MD
Director of Gastrointestinal Oncology
Intermountain Health
Maen Abdelrahim
Maen Abdelrahim, MD, PhD, B Pharm
Section Chief of Gastrointestinal Medical Oncology, Houston Methodist
Neal Cancer Center
Benjamin Weinberg
Benjamin Weinberg, MD
Associate Professor of Medicine
Lombardi Comprehensive Cancer Center at Georgetown University
Instagram
LinkedIn
X
Signatera™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.
13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy